Cellens Inc. (Seed)
Funding Details
Date Award
September 30, 2023
Vertical
Healthcare
Funding URL
View Funding Page
Premoney Valuation
$5,000,000
Valuation
$15,000,000
Funding Amount
$2,500,000
Company Info
Founding Year
2018
Traction
Cellens Inc. has secured partnerships with leading research institutions and pharmaceutical companies, demonstrating the value of their single-cell analysis platform. The company is poised for rapid growth as it continues to expand its customer base and advance its technology.
Organizations Involved
SOSV, Y Combinator, Stanford University, Genentech
Founders
Emily Chen, Michael Lee
Market
Biotechnology
Location
San Francisco, CA, US
Coinvestors
SOSV, Y Combinator
Company Description

Cellens Inc. is a biotechnology company specializing in developing novel cell analysis technologies for the healthcare industry. Their proprietary platform enables high-throughput single-cell analysis, offering unprecedented insights into cellular behavior and interactions. Cellens' technology has applications in drug discovery, precision medicine, and basic research, empowering researchers and clinicians with advanced tools to study complex biological systems at the single-cell level.

Links
Website
Back to HomeBack to Healthcare DealsView Funding Announcement